Chronic obstructive pulmonary disease and metabolic syndrome: A nationwide survey in Korea

International Journal of Tuberculosis and Lung Disease

Volumn 16, Issue 5, 2012, Pages 694-700

  Park, B H ^a   Park, M S ^a   Chang, J ^a   Kim, S K ^a   Kang, Y A ^a   Jung, J Y ^a   Kim, Young Sam ^a   Kim, Changsoo ^a  

^a Yonsei University College of Medicine   (South Korea)

Author keywords

Central obesity; Chronic obstructive pulmonary disease; Korea; Metabolic syndrome

Indexed keywords

ABDOMINAL OBESITY; ADULT; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HEALTH SURVEY; HUMAN; KOREA; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; PREVALENCE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SEX DIFFERENCE;

ADULT; AGED; CROSS-SECTIONAL STUDIES; FEMALE; FORCED EXPIRATORY VOLUME; HEALTH SURVEYS; HUMANS; INFLAMMATION; MALE; METABOLIC SYNDROME X; MIDDLE AGED; OBESITY, ABDOMINAL; PREVALENCE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; REPUBLIC OF KOREA; SEX FACTORS; VITAL CAPACITY;

EID: 84859715441     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: 10.5588/ijtld.11.0180     Document Type: Article

References (33)

1. Buist A S, McBurnie M A, Vollmer W M, et al. International variation in the prevalence of COPD (the BOLD Study): a p opulation-based prevalence study. Lancet 2007; 370: 741-750. (Pubitemid 47321907)
2. Fabbri L M, Rabe K F. From COPD to chronic systemic infl ammatory syndrome? Lancet 2007; 370: 797-799. (Pubitemid 47320803)
3. Sin D D, Wu L, Man S F. The relationship between reduced lung function and cardiovascular mortality: a population-based study and a systematic review of the literature. Chest 2005; 127: 1952-1959.
4. Yeh H C, Punjabi N M, Wang N Y, et al. Cross-sectional and prospective study of lung function in adults with type 2 diabetes: the Atherosclerosis Risk in Communities (ARIC) study. Diabetes Care 2008; 31: 741-746.
5. Selby J V, Friedman G D, Quesenberry C P Jr. Precursors of essential hypertension: pulmonary function, heart rate, uric acid, serum cholesterol, and other serum chemistries. Am J Epidemiol 1990; 131: 1017-1027. (Pubitemid 20178623)
6. Groenewegen K H, Postma D S, Hop W C, Wielders P L, Schlosser N J, Wouters E F. Increased systemic inflammation is a risk factor for COPD exacerbations. Chest 2008; 133: 350-357. (Pubitemid 351272391)
7. Fabbri L M, Luppi F, Beghe B, Rabe K F. Complex chronic comorbidities of COPD. Eur Respir J 2008; 31: 204-212.
8. Eckel R H, Grundy S M, Zimmet P Z. The metabolic syndrome. Lancet 2005; 365: 1415-1428. (Pubitemid 40523737)
9. Marquis K, Maltais F, Duguay V, et al. The metabolic syndrome in patients with chronic obstructive pulmonary disease. J Cardiopulm Rehabil 2005; 25: 226-232; discussion 233-234.
10. Watz H, Waschki B, Kirsten A, et al. The metabolic syndrome in patients with chronic bronchitis and COPD: frequency and associated consequences for systemic inflammation and physical inactivity. Chest 2009; 136: 1039-1046.
11. Leone N, Courbon D, Thomas F, et al. Lung function impairment and metabolic syndrome: the critical role of abdominal obesity. Am J Respir Crit Care Med 2009; 179: 509-516.
12. Lam K B, Jordan R E, Jiang C Q, et al. Airflow obstruction and the metabolic syndrome: the Guangzhou Biobank Cohort Study. Eur Respir J 2010; 35: 317-323.
13. Lin W Y, Yao C A, Wang H C, Huang K C. Impaired lung function is associated with obesity and metabolic syndrome in adults. Obesity (Silver Spring) 2006; 14: 1654-1661.
14. Nakajima K, Kubouchi Y, Muneyuki T, Ebata M, Eguchi S, Munakata H. A possible association between suspected restrictive pattern as assessed by ordinary pulmonary function test and the metabolic syndrome. Chest 2008; 134: 712-718.
15. Fimognari F L, Pasqualetti P, Moro L, et al. The association between metabolic syndrome and restrictive ventilatory dysfunction in older persons. J Gerontol A Biol Sci Med Sci 2007; 62: 760-765. (Pubitemid 350143608)
16. Park Y W, Zhu S, Palaniappan L, Heshka S, Carnethon M R, Heymsfield S B. The metabolic syndrome: prevalence and associated risk factor findings in the US population from the Third National Health and Nutrition Examination Survey, 1988-1994. Arch Intern Med 2003; 163: 427-436. (Pubitemid 36241019)
17. Alberti K G, Eckel R H, Grundy S M, et al. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 2009; 120: 1640-1645.
18. Korea Institute for Health and Social Affairs. Progress report on the National Health and Nutrition Survey 2001. Policy paper 2002-4. Seoul, South Korea: Ministry of Health and Welfare, Korea Institute for Health and Social Affairs, 2001.
19. American Thoracic Society. Standardization of spirometry, 1994 update. Am J Respir Crit Care Med 1995; 152: 1107-1136.
20. Kim D S, Kim Y S, Jung K S, et al. Prevalence of chronic obstructive pulmonary disease in Korea: a population-based spirometry survey. Am J Respir Crit Care Med 2005; 172: 842-847. (Pubitemid 41369067)
21. Rabe K F, Hurd S, Anzueto A, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 2007; 176: 532-555. (Pubitemid 47403272)
22. Executive Summary of the third report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001; 285: 2486-2497.
23. Geslain-Biquez C, Vol S, Tichet J, Caradec A, D'Hour A, Balkau B. The metabolic syndrome in smokers. The D.E.S.I.R. study. Diabetes Metab 2003; 29: 226-234. (Pubitemid 36813979)
24. Mannino D M, Gagnon R C, Petty T L, Lydick E. Obstructive lung disease and low lung function in adults in the United States: data from the National Health and Nutrition Examination Survey, 1988-1994. Arch Intern Med 2000; 160: 1683-1689. (Pubitemid 30367908)
25. Ford E S, Giles W H, Dietz W H. Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA 2002; 287: 356-359. (Pubitemid 34251969)
26. Pischon T, Boeing H, Hoffmann K, et al. General and abdominal adiposity and risk of death in Europe. N Engl J Med 2008; 359: 2105-2120.
27. Chen R, Tunstall-Pedoe H, Bolton-Smith C, Hannah M K, Morrison C. Association of dietary antioxidants and waist circumference with pulmonary function and airway obstruction. Am J Epidemiol 2001; 153: 157-163. (Pubitemid 32060607)
28. Canoy D, Luben R, Welch A, et al. Abdominal obesity and respiratory function in men and women in the EPIC-Norfolk Study, United Kingdom. Am J Epidemiol 2004; 159: 1140-1149. (Pubitemid 38747261)
29. Ochs-Balcom H M, Grant B J, Muti P, et al. Pulmonary function and abdominal adiposity in the general population. Chest 2006; 129: 853-862.
30. Chen Y, Rennie D, Cormier Y F, Dosman J. Waist circumference is associated with pulmonary function in normal-weight, overweight, and obese subjects. Am J Clin Nutr 2007; 85: 35-39. (Pubitemid 46067612)
31. Wannamethee S G, Shaper A G, Whincup P H. Body fat distribution, body composition, and respiratory function in elderly men. Am J Clin Nutr 2005; 82: 996-1003. (Pubitemid 43779756)
32. Santana H, Zoico E, Turcato E, et al. Relation between body composition, fat distribution, and lung function in elderly men. Am J Clin Nutr 2001; 73: 827-831. (Pubitemid 32239239)
33. Mannino D M, Thorn D, Swensen A, Holguin F. Prevalence and outcomes of diabetes, hypertension and cardiovascular disease in COPD. Eur Respir J 2008; 32: 962-969.